|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
NEW YORK, NY / ACCESSWIRE / May 5, 2017 / AVEO Pharmaceuticals, Inc. and PharmaAthene both saw losses in Thursday trading after Wall Street didn't care much for the losses both companies had in the first ...
On a per-share basis, the Annapolis, Maryland-based company said it had a loss of 3 cents. The biodefense company that develops countermeasures against biological and chemical threats posted revenue of ...
ANNAPOLIS, Md., May 3, 2017 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today reported its financial and operational results ...